Literature DB >> 12843119

Inability to decarboxylate lysine as a presumptive marker to identify Shiga toxin-producing Escherichia coli strains of serogroup O111.

Beatriz E C Guth, Tânia A T Gomes, Tânia M I Vaz, Kinue Irino.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12843119      PMCID： PMC165382          DOI： 10.1128/JCM.41.7.3450.2003

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


× No keyword cloud information.
  9 in total

1.  Phenylpropionic acid metabolism: a marker for enteropathogenic Escherichia coli clonal group 2 strains.

Authors:  V Monteiro-Neto; L R Trabulsi
Journal:  J Clin Microbiol       Date:  1999-06       Impact factor: 5.948

2.  The United States National Prospective Hemolytic Uremic Syndrome Study: microbiologic, serologic, clinical, and epidemiologic findings.

Authors:  N Banatvala; P M Griffin; K D Greene; T J Barrett; W F Bibb; J H Green; J G Wells
Journal:  J Infect Dis       Date:  2001-03-01       Impact factor: 5.226

3.  Metabolism of phenylpropionic acid in enteropathogenic Escherichia coli belonging to serogroup O111 and its application for diagnosis.

Authors:  K Irino; A M Dias; E Kano; T M Vaz; M A Kato; C R Gonçalves; M A Vieira; T A Gomes
Journal:  FEMS Microbiol Lett       Date:  2001-10-16       Impact factor: 2.742

4.  Escherichia coli serogroup O111 includes several clones of diarrheagenic strains with different virulence properties.

Authors:  L C Campos; T S Whittam; T A Gomes; J R Andrade; L R Trabulsi
Journal:  Infect Immun       Date:  1994-08       Impact factor: 3.441

5.  Community outbreak of hemolytic uremic syndrome attributable to Escherichia coli O111:NM--South Australia 1995.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  1995-07-28       Impact factor: 17.586

6.  An improved selective medium for the isolation of Escherichia coli O157.

Authors:  P A Chapman; C A Siddons; P M Zadik; L Jewes
Journal:  J Med Microbiol       Date:  1991-08       Impact factor: 2.472

7.  Phenotypic and genotypic characteristics of shiga toxin-producing Escherichia coli strains isolated from children in São Paulo, Brazil.

Authors:  Beatriz E C Guth; Sônia R T S Ramos; Aloysio M F Cerqueira; João R C Andrade; Tânia A T Gomes
Journal:  Mem Inst Oswaldo Cruz       Date:  2003-01-20       Impact factor: 2.743

Review 8.  Infection by verocytotoxin-producing Escherichia coli.

Authors:  M A Karmali
Journal:  Clin Microbiol Rev       Date:  1989-01       Impact factor: 26.132

Review 9.  Pathogenesis and diagnosis of Shiga toxin-producing Escherichia coli infections.

Authors:  J C Paton; A W Paton
Journal:  Clin Microbiol Rev       Date:  1998-07       Impact factor: 26.132
  9 in total
  3 in total

1.  Pathoadaptive mutation that mediates adherence of shiga toxin-producing Escherichia coli O111.

Authors:  Alfredo G Torres; Roberto C Vazquez-Juarez; Christopher B Tutt; J Gerardo Garcia-Gallegos
Journal:  Infect Immun       Date:  2005-08       Impact factor: 3.441

2.  Virulence properties and characteristics of Shiga toxin-producing Escherichia coli in São Paulo, Brazil, from 1976 through 1999.

Authors:  T M I Vaz; K Irino; M A M F Kato; A M G Dias; T A T Gomes; M I C Medeiros; M M M Rocha; B E C Guth
Journal:  J Clin Microbiol       Date:  2004-02       Impact factor: 5.948

3.  CadA negatively regulates Escherichia coli O157:H7 adherence and intestinal colonization.

Authors:  Roberto C Vazquez-Juarez; Jeeba A Kuriakose; David A Rasko; Jennifer M Ritchie; Melissa M Kendall; Terry M Slater; Mala Sinha; Bruce A Luxon; Vsevolod L Popov; Matthew K Waldor; Vanessa Sperandio; Alfredo G Torres
Journal:  Infect Immun       Date:  2008-09-15       Impact factor: 3.441
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.